Jeremy Goldman (Bio Med) is the principal investigator on a project that has received a $45,790 research and development grant from the Department of Health and Human Services-National Institutes of Health.
Jaroslaw Drelich (MSE) is the Co-PI on the project “Inhibition of Neointimal Hyperplasia by Zinc-Based Biodegradable Arterial Devices.”
This is the first year of a potential two-year project.
By Sponsored Programs.
